MedPlus Health Services shares fall sharply after the company reports a weaker Q1 performance. Both outlets report that Q1 net profit declines by about 21% year-on-year: NDTV puts the drop at 21.5%, to Rs 33.2 crore, while Economic Times cites a 21% YoY decline. At the same time, the company’s revenue grows strongly, around 21.8–21.9% year-on-year, reaching roughly Rs 1,880 crore in Q1. Investors react negatively to the profitability miss relative to expectations, with NDTV describing the stock decline as more than 17% and Economic Times reporting a drop of about 16%. Economic Times also notes that a brokerage, Nomura, maintains a “Buy” rating, pointing to MedPlus’ long-term growth outlook linked to its store expansion strategy, even as the near-term earnings figures disappoint.
MedPlus Health shares drop after Q1 net profit declines despite revenue growth
MedPlus Health Services shares fall sharply after the company reports a weaker Q1 performance. Both outlets report that Q1 net profit declines by about 21% year-on-year: NDTV puts the drop at 21.5%, t...
- MedPlus Health Services reports Q1 net profit declines of about 21% year-on-year.
- Q1 net profit falls to about Rs 33.2 crore.
- Revenue rises about 21.8–21.9% year-on-year to roughly Rs 1,880 crore.
- MedPlus shares drop by around 16–17% following the results.
- Nomura maintains a “Buy” rating based on long-term store expansion growth potential.
MedPlus Health Services shares tumbled after the company reported a weaker-than-expected Q1FY27. Despite healthy 21.9% revenue growth to ₹1,880 crore, investors were disappointed by the profitability miss. Brokerage Nomura maintained its 'Buy' rating, highlighting MedPlus' long-term growth potential driven by its store expansion strategy.
6 hours agoMedPlus Health Services reported a 21.5% drop in Q1 net profit to Rs 33.2 crore despite 21.8% revenue growth to Rs 1,880 crore, causing shares to fall over 17%.
8 hours ago
India’s pharma industry weighs impact of Trump’s phased tariffs on imported generic drugs
Donald Trump announces a phased tariff plan targeting imported generic medicines, aiming to reshore drug manufacturing t...
Multiple law firms announce lead plaintiff deadlines for Via Transportation securities lawsuit
Multiple PR Newswire releases in June and July 2026 report that Via Transportation, Inc. (NYSE: VIA) is facing a securit...
Sharon Osbourne urges fans to play Ozzy Osbourne’s music on first death anniversary
Sharon Osbourne marks the first anniversary of Ozzy Osbourne’s death by sharing reflections and urging fans to remember...